254 related articles for article (PubMed ID: 17597476)
1. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
[TBL] [Abstract][Full Text] [Related]
2. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
[TBL] [Abstract][Full Text] [Related]
3. Relationships of serum free thyroxine and erythrocyte measures in euthyroid HFE C282Y homozygotes and control subjects: the HEIRS study.
Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
Int J Lab Hematol; 2010 Jun; 32(3):282-7. PubMed ID: 19706067
[TBL] [Abstract][Full Text] [Related]
4. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
5. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
Barton JC; Acton RT; Dawkins FW; Adams PC; Lovato L; Leiendecker-Foster C; McLaren CE; Reboussin DM; Speechley MR; Gordeuk VR; McLaren GD; Sholinsky P; Harris EL
Genet Test; 2005; 9(3):231-41. PubMed ID: 16225403
[TBL] [Abstract][Full Text] [Related]
6. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
[TBL] [Abstract][Full Text] [Related]
7. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
[TBL] [Abstract][Full Text] [Related]
9. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
[TBL] [Abstract][Full Text] [Related]
11. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis mutations in the general population: iron overload progression rate.
Andersen RV; Tybjaerg-Hansen A; Appleyard M; Birgens H; Nordestgaard BG
Blood; 2004 Apr; 103(8):2914-9. PubMed ID: 15070663
[TBL] [Abstract][Full Text] [Related]
13. Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
McLaren CE; Barton JC; Eckfeldt JH; McLaren GD; Acton RT; Adams PC; Henkin LF; Gordeuk VR; Vulpe CD; Harris EL; Harrison BW; Reiss JA; Snively BM
Am J Hematol; 2010 Feb; 85(2):101-5. PubMed ID: 20095037
[TBL] [Abstract][Full Text] [Related]
14. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.
Barton JC; Acton RT; Lovato L; Speechley MR; McLaren CE; Harris EL; Reboussin DM; Adams PC; Dawkins FW; Gordeuk VR; Walker AP;
Clin Genet; 2006 Jan; 69(1):48-57. PubMed ID: 16451136
[TBL] [Abstract][Full Text] [Related]
15. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
[TBL] [Abstract][Full Text] [Related]
16. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
[TBL] [Abstract][Full Text] [Related]
17. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
Beutler E; Felitti V; Gelbart T; Ho N
Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877
[TBL] [Abstract][Full Text] [Related]
18. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943
[TBL] [Abstract][Full Text] [Related]
19. Platelet counts in
Barton JC; Barton JC; Acton RT
Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content.
Barton JC; Bertoli LF; Rothenberg BE
J Lab Clin Med; 2000 Jan; 135(1):96-104. PubMed ID: 10638700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
